Provided by Tiger Fintech (Singapore) Pte. Ltd.

Liquidia Technologies Inc

12.07
-0.1200-0.98%
Volume:93.82K
Turnover:1.14M
Market Cap:1.03B
PE:-7.06
High:12.19
Open:12.19
Low:11.96
Close:12.19
Loading ...

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

THOMSON REUTERS
·
03 May

Liquidia Corp - FDA Sets Pdufa Goal Date for Yutrepia Nda on May 24, 2025

THOMSON REUTERS
·
03 May

Liquidia Corp - FDA Can Grant Final Approval of Yutrepia After Blocking Regulatory Exclusivity Expires on May 23, 2025

THOMSON REUTERS
·
03 May

Liquidia rallies after judge rules against bid to delay Yutrepia

TIPRANKS
·
03 May

Liquidia up 13% to $15.85 in afternoon trading

TIPRANKS
·
03 May

Press Release: Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

Dow Jones
·
01 May

Urogen Pharma (URGN) Moves 14.1% Higher: Will This Strength Last?

Zacks
·
29 Apr

Scotiabank Sticks to Their Buy Rating for Liquidia Technologies (LQDA)

TIPRANKS
·
23 Apr

3 Top Growth Companies With Strong Insider Ownership

Simply Wall St.
·
23 Apr

BRIEF-Liquidia Corp Unit Files Patent Infringement Action Against United Therapeutics

Reuters
·
22 Apr

Liquidia Corp - Unit Files Patent Infringement Action Against United Therapeutics - SEC Filing

THOMSON REUTERS
·
22 Apr

Great week for Liquidia Corporation (NASDAQ:LQDA) institutional investors after losing 1.5% over the previous year

Simply Wall St.
·
14 Apr

Liquidia Price Target Maintained With a $25.00/Share by Needham

Dow Jones
·
10 Apr

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire
·
01 Apr

Liquidia Says FDA to Review New Drug Application for Yutrepia

MT Newswires Live
·
28 Mar

Liquidia Corp - FDA Sets Pdufa Goal Date of May 24, 2025 for Yutrepia

THOMSON REUTERS
·
28 Mar

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for Yutrepia™ (Treprostinil) Inhalation Powder

THOMSON REUTERS
·
28 Mar

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

GlobeNewswire
·
28 Mar

Liquidia Announces Poster Presentations at the American Thoracic Society (ATS) 2025 International Conference

GlobeNewswire
·
27 Mar

Discover 3 Top Growth Companies With Significant Insider Ownership

Simply Wall St.
·
25 Mar